Follow us Flash

No 70, February 2016
NDT Journal

Tolvaptan use in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Group on Inherited Kidney Disorders and the ERA-EDTA Guideline body the European Renal Best Practice
The European Medicines Agency recently approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adult patients with chronic kidney disease stages 1–3 at initiation of treatment with evidence of rapidly progressing disease. The ERA-EDTA Working Group on Inherited Kidney Disorders and the European Renal Best Practice have prepared a timely position statement with the aim of providing guidance for making the decision as to which ADPKD patients to treat with tolvaptan. The present position statement includes a series of recommendations resulting in a hierarchical decision algorithm that encompasses a sequence of risk-factor assessments in a descending order of reliability.

Read more

NDT Call for papers

NDT special issue 'The therapeutic portfolio for glomerular diseases' – Call for papers
NDT is now accepting papers for a special issue: 'The therapeutic portfolio for glomerular diseases: present and future opportunities', guest edited by Fernando C. Fervenza and Daniel Cattran. The objective is to provide the nephrologist with an up-to-date summary of important developments in glomerular based diseases where basic research and clinical research merge to aim at achieving a new and improved management and therapeutic approach for our GN patients.  The submission deadline is April 15th, 2016.

Read more

WKD 2016

ERA-EDTA Photo Contest on occasion of WKD 2016
This year´s theme of the World Kidney Day is “Kidney Disease & Children. Act Early to Prevent It!” If you are a full ERA-EDTA member and under 40 years of age, you are invited to submit your pictures, which should be somehow connected to the World Kidney Day´s theme. The top three submissions will win a free Congress Membership for the Vienna Congress. The submitted photos will be posted on Instagram and the number of “likes” will decided the winners. The winning photos will be put on display during the next ERA-EDTA Congress in Vienna!

Read more

ndt and ckj app

NDT and CKJ Journals App
The app for both iPhone and iPad provides access to contents from both of these prestigious journals! Issues and articles can be downloaded when you are online, so that you can read them later when you are offline. So whether you are connected to the internet or not, you can always access your favorite articles. Just open iTunes and download the app. Then you can browse the contents, search the entire journal archive, and save the most relevant articles to your “Favorites”.

Read more

Upcoming events

Tartu

Introductory Course on Epidemiology
February 18-19, 2016
Tartu, Estonia

Leipzig

11th Leipzig Renal Biopsy Course
March 4-5, 2016
Leipzig, Germany

Hamburg

'Omics' contributions to physiopathology in CKD and new actors
April 1, 2016
Hamburg, Germany

Leiden

NDT course for reviewers-to-be
April 4-5, 2016
Leiden, The Netherlands

ERA-EDTA Meetings Endorsed
Come to Vienna 2106!
fb
twitter
google
youtube
vimeo
linkedin
Instagram
Follow us Flash - c/o ERA-EDTA Headquarters - Via XXIV Maggio 38 - 43123 Parma - Italy followus@era-edta.org
The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003. If at any time you wish to change personal information that is incorrect or wish to have your personal data deleted, please REPLY this email and specify ‘REMOVE ME FROM YOUR DATABASE’. ERA-EDTA will meet such requests at the earliest possible opportunity by deleting or amending your personal information.